Immuneering (IMRX) Shares Outstanding (Weighted Average) (2020 - 2024)
Historic Shares Outstanding (Weighted Average) for Immuneering (IMRX) over the last 5 years, with Q3 2024 value amounting to $29.8 million.
- Immuneering's Shares Outstanding (Weighted Average) rose 196.67% to $29.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.8 million, marking a year-over-year increase of 196.67%. This contributed to the annual value of $28.4 million for FY2023, which is 769.21% up from last year.
- Latest data reveals that Immuneering reported Shares Outstanding (Weighted Average) of $29.8 million as of Q3 2024, which was up 196.67% from $29.7 million recorded in Q2 2024.
- Immuneering's Shares Outstanding (Weighted Average)'s 5-year high stood at $29.8 million during Q3 2024, with a 5-year trough of $5.0 million in Q2 2020.
- In the last 5 years, Immuneering's Shares Outstanding (Weighted Average) had a median value of $26.4 million in 2022 and averaged $20.2 million.
- Per our database at Business Quant, Immuneering's Shares Outstanding (Weighted Average) rose by 8.94% in 2021 and then surged by 43256.76% in 2022.
- Immuneering's Shares Outstanding (Weighted Average) (Quarter) stood at $5.0 million in 2020, then skyrocketed by 175.0% to $13.6 million in 2021, then soared by 93.84% to $26.4 million in 2022, then rose by 7.69% to $28.4 million in 2023, then rose by 5.02% to $29.8 million in 2024.
- Its last three reported values are $29.8 million in Q3 2024, $29.7 million for Q2 2024, and $29.4 million during Q1 2024.